About Odonate Therapeutics™
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent belonging to a class of drugs known as taxanes, which are widely used in the treatment of cancer. In December 2017, Odonate initiated CONTESSA, a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with locally advanced or metastatic breast cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
|
|
|
1-10 employees
View all Odonate Therapeutics™ employees
|
|
Pharmaceuticals
|
|
San Diego, CA 92121, US
|
|
2013
|
|
Oncology, Clinical, Drug Development, Oncology, Drug Development, Clinical
|
Odonate Therapeutics™ Alternatives
Odonate Therapeutics™ Staff Directory
Search Odonate Therapeutics™ Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
